Skip to main content
Health Care Science logoLink to Health Care Science
. 2022 Dec 21;2(1):45–59. doi: 10.1002/hcs2.28

Socioeconomic and epidemiological milieu of maternal death due to eclampsia in West Bengal, India: A mixed methods study

Md Illias Kanchan Sk 1,
PMCID: PMC11080819  PMID: 38939742

Abstract

Background

West Bengal is experiencing an unanticipated risk of eclampsia among pregnant women and it persists as the leading cause of maternal mortality. This study aimed to investigate the predictors for maternal deaths due to eclampsia in West Bengal.

Methods

The study adopted retrospective mixed methods covering facility and community‐based maternal death review approaches. Facility‐based data were used for 317 deceased cases wherein the community‐based review approach was used in 40 cases. An in‐depth interview was also performed among 12 caregivers.

Results

One‐third of maternal deaths occurred due to eclampsia, and this accounted for the leading cause of maternal deaths in West Bengal. A younger age, a primigravida or nulliparous status, absence of antenatal care (ANC), and residence in rural areas appeared to have the highest risk of developing eclampsia. The majority of pregnant women had an irregular antenatal check‐up history, particularly during the second trimester of pregnancy. The rate of eclampsia‐related maternal death was higher in women residing more than 49 km from the studied hospitals. Most of the deceased women were referred to three or more hospitals before their death. Gravidity, the number of ANC visits, the mode of delivery, and delays at different levels were significant confounders of death due to eclampsia. The risk of death due to eclampsia was two times higher among women without ANC and those who had a cesarean section than that in their counterparts.

Conclusions

Women in West Bengal have a high risk of preeclampsia and eclampsia resulting in maternal mortality and morbidity. Gravidity, the number of ANC visits, the mode of delivery, and delays in recognition of eclampsia contribute to the risk of maternal deaths. The establishment of separate eclampsia units, enhanced screening, and preventive and treatment procedures may optimize managing eclampsia.

Keywords: eclampsia, maternal mortality, determinants, West Bengal, India


Hemorrhage estimated to be responsible for more than 25% of all maternal deaths and accounted as a major leading cause of maternal deaths in India and elsewhere. Studies from our selected area (West Bengal) show an anomaly finding in contrast to the Indian and global scenario which manifest that eclampsia or hypertensive disorders of pregnancy is the single most frequent cause of maternal deaths. The study aims to investigate the predictors for eclamptic maternal deaths in West Bengal and to compare it with non‐eclamptic maternal deaths.

graphic file with name HCS2-2-45-g002.jpg


Abbreviations

ANC

antenatal care

ANM

auxiliary nurse midwife

AOR

adjusted odds ratio

ASHA

accredited social health activist

CBMDR

community‐based maternal death review

CI

confidence interval

FBMDRf

facility‐based maternal death review

IFA

iron and folic acid

KMC&H

medical college and hospital, Kolkata

MMC&H

Malda medical college and hospital

MMR

maternal mortality ratio

TT

tetanus toxoid

1. BACKGROUND

Eclampsia adversely affects maternal and perinatal health, particularly in low resource countries, which contributes to substantial fetal and maternal mortality [1, 2]. In 2015, approximately 12%−16% of all maternal deaths were attributed to complications of pregnancy‐induced hypertension [3]. A disproportionate high rate of maternal death due to eclampsia has been reported in low and middle‐income countries, with 76,000 annual maternal deaths [2, 4]. Preeclampsia and eclampsia are prevailing causes of maternal mortality in India, and 9% of all maternal mortality is caused by eclampsia [5, 6].

Unsurprisingly, the incidence of preeclampsia and eclampsia is declining in developed nations. Nonetheless, the incidence of this life‐threatening morbidity has remained constant over the last few decades in low and middle‐income countries [1, 7]. The incidence of eclampsia in developed nations is approximately 1 in 2000 to 1/3448 deliveries [8], while in India, the incidence of eclampsia ranges from 1.56% to 3.75% [6, 9]. The occurrence of eclampsia and its preceding condition, preeclampsia, is observed in varying degrees in Indian States [10, 11].

West Bengal is located in the eastern part of India, and has a high risk of eclampsia in pregnant women. The incidence rate of eclampsia is >3%, with an 8%−19% fatality rate in West Bengal [12, 13]. West Bengal is currently experiencing a 10−30 times higher incidence and case fatality rate of eclampsia than developed nations [14, 15]. A recent estimate has shown that eclampsia accounts for 43.4% of total maternal deaths, with a case fatality rate of 8.061% [12]. Therefore, West Bengal has the highest rate of maternal death due to eclampsia in India [16]. The disproportionate high rate of maternal death due to eclampsia in West Bengal was the indication of lowest percentage (19.86%) of declining maternal mortality ratio among the various states of India [17].

The etiology of eclampsia remains unknown and its pathophysiology is still poorly understood [2]. Various studies have focused on identifying maternal death due to eclampsia [6]. However, studies strictly highlighting patients with eclampsia and factors affecting eclampsia‐related maternal death are rare [10]. In addition, most studies related to eclampsia were based only on one approach of facility‐based or community‐based. However, no studies have applied both of these approaches in a single study. Furthermore, inadequate health statistics and a lack of addition of some significant confounders are notable deficiencies that have limited previous Indian studies. Therefore, this study aimed to investigate the main predictors for maternal death due to eclampsia and compare characteristics between pregnant women who died from eclampsia and those who died from other causes.

2. METHODS

2.1. Study design and settings

This was a retrospective mixed methods study, which used facility‐ and community‐based approaches to examine the deaths that occurred during pregnancy, childbirth, and puerperium. The study was conducted between November 2013 and October 2015 at Malda Medical College (MMC&H) and Hospital and Medical College and Hospital, Kolkata (KMC&H), which are situated in the northern and southern part of West Bengal, India, respectively. These two hospitals are the major tertiary‐level healthcare units in eastern India, and they conduct more than 27,000 deliveries annually (https://www.wbhealth.gov.in/). The majority of pregnant women with complicated and irreversible problems from neighboring rural and urban areas, and also from other parts of India, visit these hospitals to use basic and comprehensive emergency health facilities. Therefore, these hospitals are a representative sample to help understand the contribution of eclampsia to maternal mortality in the community as a whole.

2.2. Data sources

2.2.1. Secondary sources

In this study, hospital‐based records were used as secondary data of 317 women who died owing to pregnancy‐ and child‐birth‐related causes in the Department of Obstetrics and Gynecology of the selected hospitals. The details of all 317 maternal deaths were acquired using the facility‐based maternal death review form. The individual case sheets, death registers, referral letters, medical records, and previous antenatal care (ANC) records were reviewed to retrieve the data related to the sociodemographic profile, the clinical profile, medical and obstetric history, health‐seeking behavior, the referral status, the mode of delivery, the type of delay, causes of deaths, and the feto‐maternal outcome of the deceased women.

2.2.2. Primary sources

Forty community‐based maternal death reviews (20 women who died from eclampsia and 20 women who did not die from eclampsia) were performed in the community. The 40 cases were selected from the 317 maternal deaths that occurred in the studied hospitals. We used the residential address maintained in the selected hospitals to reach the respondents. We interviewed the family members and others who had witnessed any stage during the process leading to death. These people were mainly family members, neighbors, and relatives. In some cases, both sets of relatives from the parent's side and the in‐law's side were also interviewed together. In primary data collection, this study adopted the maternal mortality questionnaire, which incorporated the National Rural Health Mission‐validated community‐based maternal death review questionnaire.

Information pertaining to the sociodemographic characteristics, health‐seeking behavior, the referral history, premorbid condition, types of delays leading to maternal death, and strategy required to prevent maternal death were also obtained by using semistructured open‐ended questions. This information was obtained from 12 health workers of various hierarchies who were associated with the maternal deaths or who participated in the provision of care to the deceased. In‐depth interviews were performed in these 12 caregivers who comprised 2 accredited social health activists or auxiliary nurse midwives, 6 healthcare providers from first, second, and third levels healthcare facilities, and 4 were from the selected hospitals. Figure 1 shows the process of selecting interviewees. Most of the interviews were conducted in Bengali (regional language), but a few interviews were also performed in Hindi (official language of India). Written informed consent was obtained from all family members of the deceased women and also from hospital authorities.

Figure 1.

Figure 1

Process of reaching study cases and interviewees. ASHA, accredited social health activists; KMC&H, medical college and hospital, Kolkata; MMC&H, Malda medical college and hospital.

2.3. Definitions of outcome and exposure variables

2.3.1. Outcome variables

Of the 317 pregnancy‐related deaths, 105 were determined as death due to eclampsia, 209 deaths were not due to eclampsia, and the remaining 3 were unidentified. The recognized cause‐specific maternal deaths were dichotomized into maternal death due to eclampsia and not due to eclampsia, and used as the main outcome variable. The death of women caused by eclampsia during pregnancy, childbirth, and puerperium was considered as maternal death due to eclampsia. The World Health Organization [18] definition and classification of causes of maternal deaths were adopted to define and classify the deaths during pregnancy and childbirth.

2.3.2. Exposure variables

The following individual characteristics were considered as predictor variables: maternal age, gestational age, locality of residence, religion, gravidity, parity, having an ANC card or the number of ANC visits, place of delivery, mode of delivery, referral status, distance from the hospital, time interval from developing complications to admission, mother's status on admission, reasons for admission, stage of pregnancy at death, and types of delays.

A delay was defined as a delay in deciding to seek appropriate care by individuals, family or both (type 1 delay), a delay in reaching an adequate healthcare facility (type 2 delay), and a delay in receiving adequate care when a facility was reached (type 3 delay).

2.4. Data analysis

Bivariate analysis with the χ  2 test was applied for the comparison between deceased cases of eclampsia and those without eclampsia in relation to various exposures. The binary logistic regression model was applied to estimate adjusted odds ratios (AORs) with their respective 95% confidence intervals (CIs) to identify the main confounders associated with death due to eclampsia. Differences were considered significant if p was <0.05. STATA version 13.0/SE was used for all statistical analyses. Personal interviews were conducted with the family members and medical staff. Most of the interviews were digitally recorded and later transcribed and translated into English. The English transcript materials were imported into QRS Nvivo, and categorized and analyzed by adopting the thematic approach.

The credibility, transferability, dependability, and confirmability of the data were taken into consideration to ensure the reliability and trustworthiness of the qualitative aspect of the study. The data were double‐checked, the length of time during the interview was checked and a rapport was created with the respondents to produce valid data. The findings of this qualitative study were compared with quantitative findings. The qualitative findings were also corroborated with other similar national and global level studies. There was no controlled environment to conduct the research.

3. RESULTS

3.1. Underlying causes of death

The total number of maternal deaths in the selected health facilities was 317 over a 2‐year period (Table 1). More than 70% of the maternal deaths were the result of direct obstetric causes, and 16.7% of these deaths were due to indirect obstetric causes. Eclampsia contributed to one‐third of deaths, and it accounted for the leading cause of maternal death in West Bengal.

Table 1.

Underlying causes of deaths (N = 317)

Causes of deaths ICD‐10 code No of women Percent
Direct causes (n = 230, 72.6) Hemorrhage O45.8, O46.0, 072.0, 072.1 75 23.7
Infections/sepsis O85, O86 31 9.8
Abortion O03, O04, O05.2, O07.6, O07.7 9 2.8
Eclampsia O14.1, O14.9, O15.0, O15.1, O15.2 105 33.1
Obstructed labor/rupture uterus O63, O64, O65.4, O66.8 10 3.2
Other direct causes (n = 31, 9.8) Ectopic pregnancy O00.0, O00.1, O00.8, O00.9 11 3.5
Pulmonary embolism O22, 088, 088.2 17 5.4
IUFD with DICa O31.2, O35.7, O36.4, O45.0, O46.0, O67.0 3 0.9
Indirect causes (n = 53, 16.7) Jaundice O98.4 11 3.5
Heart diseases O99.4 20 6.3
Anemia O99.0 20 6.3
Diabetes mellitus O24.0, O24.1, O24.2, O24.3, O24.9 1 0.3
Acute renal failure O72.1, 090.4 1 0.3
Undetermined 3 0.9
a

Intrauterine fetal death with disseminated intravascular coagulation in pregnancy (IUFD with DIC).

3.2. Sociodemographic and pregnancy‐related characteristics in women with and without eclampsia‐related death

Variation in the mortality rate started to increase steadily after 18 years of age and continued up to 25 years in women with and without eclampsia who died (Figure 2). The risk of dying in women during gestation and childbirth due to eclampsia‐related causes was higher in those aged 19−25 years. The majority (85%) of deceased women who had eclampsia lived in rural areas (Table 2). Primigravidas (40%) appeared to have the highest risk of developing eclampsia. The number of eclampsia‐related maternal deaths decreased as the gravidity increased, while the gravidity of women was inversely related to non‐eclampsia‐related maternal deaths. Similar findings were also observed for parity. The number of eclampsia‐related maternal deaths was higher in women residing more than 49 km from the final hospital. There was no significant difference in the number of maternal deaths due to eclampsia and non‐eclampsia causes in women who lived at a relatively shorter distance (within 0−33 km) from the final hospital (Figure 3). After a distance of 33 km, the variation in maternal deaths due to eclampsia and non‐eclampsia causes increased with increasing distance up to 100 km, and then eclampsia cases surpassed non‐eclampsia cases.

Figure 2.

Figure 2

Eclamptic and non‐eclamptic maternal deaths by age at death

Table 2.

Distribution of eclamptic and non‐eclamptic maternal deaths by selected background characteristics

Characteristics Eclamptic deaths (n = 105) Non‐eclamptic deaths (n = 209) Total (n = 314) χ  2 Value p Value
Number Percent Number Percent Number Percent
Age at death
<24 68 64.8 105 50.2 173 55.1
25−29 20 19.0 59 28.2 79 25.2 6.03* 0.049
>29 17 16.2 45 21.5 62 19.7
Religion 0.84 0.360
Hindu 58 55.2 104 49.8 162 51.6
Muslim 47 44.8 105 50.2 152 48.4
Place of residence 0.12 0.732
Rural 89 84.8 174 83.3 263 83.8
Urban 16 15.2 35 16.7 51 16.2
Gravida 16.00*** 0.000
Primigravida 42 40.0 45 21.5 87 27.7
Gravida 2 38 36.2 73 34.9 111 35.4
>2 Gravida 25 23.8 91 43.5 116 36.9
Parity 13.12** 0.001
Nullipara 45 42.9 51 24.4 96 30.6
Primipara 37 35.2 80 38.3 117 37.3
>Primipara 23 21.9 78 37.3 101 32.2
No of living children 10.06** 0.007
0 53 50.5 68 32.5 121 38.5
1 31 29.5 75 35.9 106 33.8
>1 21 20.0 66 31.6 87 27.7
Distance between home and hospitals 3.16 0.206
<25 36 34.3 73 34.9 109 34.7
25−49 27 25.7 71 34.0 98 31.2
>49 42 40.0 65 31.1 107 34.1
Total 105 100 209 100.0 314 100.0
*

p < 0.05.

**

p < 0.01.

***

p < 0.001.

Figure 3.

Figure 3

Eclamptic and non‐eclamptic deceased women according to distance from final hospital

3.3. Heath‐seeking behavior and obstetric characteristics in women with and without eclampsia‐related death

A total of 81% of all deceased women who had eclampsia were referred from various other lower‐level healthcare units (Table 3). The majority (approximately three quarters) of eclampsia‐related maternal deaths were found in those without ANC visits, whereas 50% of non‐eclampsia‐related maternal deaths occurred in those without ANC visits. Additionally, only 6 deceased women who had eclampsia had full antenatal check‐ups (three to four times), and 35 of 209 deceased women who did not have eclampsia used ANC three to four times. Of the 105 deceased women who had eclampsia, 13% sought medical care within 5 h of developing complications. However, 36% of these women sought medical care between 6 and 12 h, and more than half of them took more than 12 h to seek admission for management of complications. Eighty‐three (79.0%) and 144 (68.9%) women were unstable and 22 (2%) and 65 (31.1%) were stable on admission in women with eclampsia‐related death and those with non‐eclampsia‐related death, respectively. The most commonly observed mode of delivery was cesarean section in women with eclampsia‐related death (54.3%) and in those with non‐eclampsia‐related death (46.5%).

Table 3.

Distribution of eclamptic and non‐eclamptic deceased women by referral status and health seeking behavior

Characteristics Eclamptic deaths (n = 105) Non‐eclamptic deaths (n = 209) Total (n = 314) χ  2 Value p Value
Number Percent Number Percent Number Percent
Referral status
Yes 85 81 167 79.9 252 80.3 0.048 0.826
No 20 19 42 20.1 62 19.7
ANC visit
No 74 73.3 100 50 174 57.8 16.19*** 0.000
1−2 21 20.8 65 32.5 86 28.6
3−4 6 5.9 35 17.5 41 13.6
Period of admission
AN period 32 30.5 69 33 101 32.2
Intrapartum 31 29.5 64 30.6 95 30.3 0.414 0.813
Postpartum/natal 42 40 76 36.4 118 37.6
Duration of onset of complication to admission (h)
<6 13 12.4 31 14.8 44 14 0.35 0.839
6−12 38 36.2 74 35.4 112 35.7
>12 54 51.4 104 49.8 158 50.3
Condition on admission
Stable 22 21 65 31.1 87 27.7 3.59* 0.048
Unstable 83 79 144 68.9 227 72.3
Labor pain
Yes 77 73.3 141 76.2 218 75.2 0.30 0.585
No 28 26.7 44 23.8 72 24.8
Duration of labor (h)
<6 21 26.9 45 31.3 66 29.7 1.71 0.426
6−12 36 46.2 71 49.3 107 48.2
>12 21 26.9 28 19.4 49 22.1
Mode of delivery
Undelivered 20 19 31 16.8 51 17.6 5.18 0.159
Spontaneous vaginal 23 21.9 63 34.1 86 29.7
Vacuum/forceps 5 4.8 5 2.7 10 3.4
Cesarean section 57 54.3 86 46.5 143 49.3
Period of death
AN period 14 13.3 44 21.1 58 18.5 2.83 0.243
Intrapartum 9 8.6 18 8.6 27 8.6
Postpartum/natal 82 78.1 147 70.3 229 72.9

Abbreviation: ANC, antenatal care.

*

p < 0.05.

***

p < 0.001.

3.4. Distribution and association of women with and without eclampsia‐related death in relation to the type of delay

A total of 80% of women with eclampsia‐related death and 56.9% of those with non‐eclampsia‐related death had any type of delay (Table 4). More than two thirds of women with eclampsia had delay in seeking care (type 1 delay), 46% had a delay in reaching a first level health facility (type 2 delay) and approximately one quarter had a delay in receiving adequate care in a facility (type 3 delay). Type 1 delay contributed to two thirds of death due to eclampsia, but contributed to only 39% of death due to non‐eclampsia causes (Table 4).

Table 4.

Distribution of eclamptic and non‐eclamptic maternal deaths by delay

Eclamptic deaths (n = 105) Non‐eclamptic deaths (n = 209) Total (n = 314)
Characteristics Number Percent Number Percent Number Percent χ  2 Value p Value
Delay in seeking care
Yes 70 66.7 81 38.8 151 48.1 21.81*** 0.000
No 35 33.3 128 61.2 163 51.9
Delay in reaching first level health facility
Yes 48 45.7 59 28.2 107 34.1 9.51** 0.002
No 57 54.3 150 71.8 207 65.9
Delay in receiving adequate care in facility
Yes 27 25.7 33 15.8 60 19.1 4.45* 0.035
No 78 74.3 176 84.2 254 80.9
Any delay
Yes 84 80.0 119 56.9 203 64.6 16.27*** 0.000
No 21 20.0 90 43.1 111 35.4
*

p < 0.05.

**

p < 0.01.

***

p < 0.001.

3.5. Factors associated with maternal death related to eclampsia

The binary logistic regression showed a robust association between gravidity (AOR: 0.59; 95% CI: 0.53–0.96), ANC (AOR: 2.13; 95% CI: 1.19–3.12), mode of delivery (AOR: 2.41; 95% CI: 1.27–3.23), and any delay (AOR: 0.60; 95% CI: 0.27–0.89) for eclampsia‐related maternal death (Table 5). The odds ratio of eclampsia‐related maternal death was two times higher in women without ANC than in women who received ANC.

Table 5.

Adjusted odds ratio (95% CI) showing factors influencing the eclamptic deceased women

Characteristics Odds ratio 95% CI
Age at death
18−22(R)
23−27 2.44 0.89−6.66
28−32 1.40 0.41−4.77
≥33 0.68 0.10−4.33
Place of residence
Rural(R) 1.32 0.495−3.54
Urban
Religion
Hindu(R) 1.11 0.52−2.38
Muslim
Gravida
Primigravida(R)
2nd 0.59** 0.53−0.96
3rd 0.04 0.01−4.19
≥4th 0.09 0.05−6.41
Parity
Nullipara(R)
Primiparous 0.39 0.03−4.34
2nd parous 4.06 0.10−7.58
≥3 2.35 0.02−5.41
ANC care
Full(R) 2.13*** 1.19−3.12
No
Mode of delivery
Vaginal(R) 2.41** 1.27−3.23
Cesarean
Referral status
Yes(R) 1.66 0.63−4.34
No
Condition on admission
Stable(R) 1.05 0.36−5.04
Unstable
Delay
Yes® 0.60** 0.27−0.89
No

Abbreviations: ANC, antenatal care; CI, confidence intervals; R, reference category.

**

p < 0.01.

***

p < 0.001.

4. RESULTS FROM THE COMMUNITY‐BASED STUDY

4.1. Antenatal history, complications during pregnancy and awareness

The community‐based study showed a mixed reaction towards ANC check‐ups. Some respondents replied favorably regarding ANC check‐ups and some replied against it. All of the patients had a history of access to ANC. Many of them even had access to three or more ANC visits. However, many of the deceased women's relatives never took the women to more than one ANC session. Some of them visited two thirds of 1 km from a health subcenter for antenatal check‐ups. Some women also visited private hospitals and some even consulted homeopathic doctors. The antenatal and complication history is discussed in the context of patients with eclampsia and those without eclampsia for better understanding the circumstances leading to death.

An important finding from the interviews is that women who had suffered from eclampsia were deprived of ANC at the second trimester. One of the respondents reported “Our ‘Boudi’ was admitted to Ramharipur PHC for a few days in her first trimester, but after discharge, she did not have any problems. Therefore, we did not take her there any more. We took her to the hospital once more when she developed a severe headache 1 to 1½ months before her expected day of delivery” (deceased 22‐year woman's sister‐in‐law).

However, the majority of deceased women without eclampsia had a history of using ANC in all three trimesters. When describing ANC events of a deceased woman without eclampsia, her husband noted that “We wanted our daughter‐in‐law to have a healthy and safe delivery. Therefore, we took her every time for a check‐up” (narrated by the woman's mother‐in‐law).

In this study, most relatives of deceased women with eclampsia were not acquainted with symptoms of high blood pressure, headache or swelling. One respondent reported that the pregnant woman complained of a headache, and swelling of the face and limbs as follows: “Our daughter‐in‐law was sitting in the courtyard and suddenly complained of uneasiness and blurring of vision. We took her to a private doctor. The doctor diagnosed her with high blood pressure. We did not know before this diagnosis that the complication was due to a high blood pressure” (father‐in‐law of the deceased woman).

4.2. Analysis of the referral history

Community‐based in‐depth interviews showed that majority of the deceased women had been referred from level 1, 2, or 3 healthcare units and reached the studied hospitals in a critical condition. This referral chain was categorized into two schematic overviews of eclampsia and non‐eclampsia for better understating.

Eclampsia schematic overview: Most of the women who died due to eclampsia had been taken to more than three health facilities to reach Kolkata or Malda hospital (Figure 4a). A mother‐in‐law of a 20‐year‐old deceased woman reported the following: “Our daughter‐in‐law complained of blurring of vision on Sunday at 4.00 p.m. In the evening, we took her to a private doctor's clinic, and he gave her medicine. He said that she would be alright, but she developed complications again late in the night. In the morning, we took her to the primary health center, which was 2 km away, and she was admitted there. She was referred to the secondary level health setup again at 5 p.m. when her condition deteriorated. We reached the local hospital at approximately 8 p.m. the second day. She was kept there for 2 days. When she was in a critical condition, she was referred to a higher‐level hospital, which was a subdivisional hospital. A male neonate was delivered by cesarean section at the subdivisional hospital. Five hours after the delivery, the doctors told us that the patient was having convulsions and that she needed to be taken to Malda. Three hours after admission to Malda Medical College and Hospital, the patient died.”

Figure 4.

Figure 4

(a) Schematic overview of referral history of eclamptic deceased women. (b) Schematic overview of referral history of non‐eclamptic deceased women.

Non‐eclampsia schematic overview: Most of the deceased women who had eclampsia were referred to three or more hospitals before their deaths. However, non‐eclampsia cases were referred to one or two hospitals (Figure 4b).

4.3. Reasons for the referrals

The main reasons for referring the patient were hemorrhage, eclampsia, and preeclampsia. Severe anemia, jaundice, and heart problems in pregnancy were also recorded in the admission documents. A poor socioeconomic status, early age of marriage, and lack of proper food intake aggravated the situation.

The irreversible condition of a patient is due to poor management in peripheral health institutions. In this study, the patients were transferred to the final hospitals without examining their blood pressure or other medical conditions. Sometimes, patients with eclampsia were only administered 5−6 g of magnesium sulfate instead of a 14 g dose. Such a situation was clearly stated by a medical practitioner in one of the final hospitals: “We do not doubt patients requiring cesarean section are not examined properly, and for managing f eclampsia, no proper doses are provided. These are the reasons that accelerate mortality.”

5. DISCUSSION

Preeclampsia and eclampsia constitute a major public health concern in West Bengal and affect reproductive‐aged women and their offspring. Furthermore, preeclampsia and eclampsia increase the risk of the double burden of disease (risk of cardiovascular and neurological disease) in later life [7]. The etiology of eclampsia remains unknown. Therefore, this study attempted to determine the overall circumstances contributing to maternal death by using facility and community‐based maternal death review approaches in a region with a high number of eclampsia cases in India.

The present study showed that there were notable differences in background maternal characteristics of the studied patients with and without eclampsia‐related death. Death due to eclampsia was significantly more common in the younger age group (<24 years), primigravidas, nulliparous women, women without ANC, and women who lived in rural areas than in their counterparts [12, 19]. Primigravida women and a younger age group appeared to have the highest risk of developing complications, which are similar results to those found in other studies [20, 21]. Social customs, a low socioeconomic status and illiteracy are thought to be responsible for the high rate of eclampsia‐related death in younger and primigravida mothers [17].

Notably, eclampsia‐related maternal death was more common than non‐eclampsia‐related maternal death in women who resided in distant areas from the studied hospitals. This variation in the rate of death between these two groups of women raises an important issue concerning delays in referral of patients with eclampsia, the availability of magnesium sulfate and good nursing care in referral healthcare units [22]. Therefore, the heterogeneity between regions relating to eclampsia‐ and non‐eclampsia‐related deaths in this study might be a reflection of how distant factors play an instrumental role [1, 23]. The disparity of the prevalence of preeclampsia/eclampsia is not only a reflection of the variability in maternal risk factor distribution, but may also be associated with variations in the facility and regional characteristics, such as diagnostic capacities or the accessibility of services [2].

The irregular and lack of ANC showed a strong relationship with eclampsia‐related maternal death. This study showed that the likelihood of having eclampsia‐related maternal death was two times higher in women without ANC than in those who received full ANC. There was an inverse association between eclampsia‐related maternal death and increased ANC coverage, which is consistent with previous studies [24, 25]. The late second and early third trimesters are the most critical stages for developing eclampsia, and a low reporting rate of prenatal care during these gestational ages are responsible for the failure of detecting preeclampsia [2, 17]. The community‐based in‐depth interviews in this study showed that the majority of pregnant women had an irregular antenatal check‐up history, particularly during the second trimester of pregnancy. There was a twofold increase in the risk of maternal death in patients with eclampsia, mostly due to a delay in seeking care, a delay in transportation, a delay in referral, poor management, and a shortage of an intensive care unit for eclampsia [23]. Illiteracy and unawareness of life‐threatening signs, a low and late appearance of symptomatic patients during the antenatal period at healthcare units and poor administration of magnesium sulfate in patients with eclampsia at the referral time led to the progression of complications of eclampsia. This in turn could result in maternal death [23, 26]. The community‐based in‐depth interviews showed that most of the deceased women who had eclampsia were referred to three or more hospitals before their death compared with deceased women without eclampsia who were referred to one or two hospitals. The in‐depth‐interviews with the healthcare providers suggested that the critical condition of a patient was due to poor management in peripheral health institutions. These patients are being transferred to the final hospitals without examining blood pressure or other medical conditions [27].

The burden of eclampsia‐related maternal deaths in the study population showed considerable variation regarding the mode of delivery. The rate of maternal death attributed to eclampsia was higher in women who had a cesarean section than in those who had a normal delivery [28, 29]. Studies have shown that a prior surgical cesarean section leads to an increase to the progression of preeclampsia in a subsequent pregnancy. The extended interval between pregnancies among patients who previously experienced cesarean section is a major risk factor for preeclampsia [30, 31], suggesting that the advantage of a high parity regarding the risk of preeclampsia is only transient. This evidence supports the considerably high and increasing cesarean section rate in West Bengal in India [32, 33]. This may explain the preponderance of death due to eclampsia in patients who have a cesarean section in this region. The most plausible explanation is that eclampsia in severely frail patients requires extensive administration of magnesium sulfate at referral healthcare units, and the poor administration of magnesium sulfate leads to a large number of cesarean sections in the region [12, 34].

5.1. Strengths and limitations

This mixed method study has a number of limitations. The hospital records used in this study may not have been good quality, including incomplete entries. The number of ANC visits was analyzed in the study, but information such as clinical examinations, use of tetanus toxoid immunization and iron and folic acid tablets, could not be ascertained from the case records. This lack of information could have had a major effect on differentiating between deceased women with and those without eclampsia. A community‐based maternal death review also has limitations because it solely depends upon the narration provided by family members. Therefore, this review is subject to recall bias. This study relied on community reports of signs and symptoms of illness to classify the medical causes of death. In spite of these limitations, this study contributes to understanding the severity of eclampsia in relation to maternal health in our society. Furthermore, our findings could help in identifying confounding factors and deficiencies in the healthcare delivery system, and might contribute to planning strategies and interventions for curtailing pregnancy‐related death due to eclampsia.

6. CONCLUSIONS

The study area has an unanticipated risk of eclampsia among pregnant women, which persists as the leading cause of maternal mortality. Eclampsia‐related maternal deaths were more common than non‐eclampsia‐related deaths in areas that were distant from the hospitals in this study. Gravidity, the number of ANC attendance and delays at different levels play a major role in determining the preponderance of eclampsia‐related maternal death. This study suggests that ensuring regular ANC (particularly during the late second or early third trimester), early referral and sharing knowledge about life‐threatening signs are important to avert death due to eclampsia. The establishment of separate eclampsia units at lower level health facilities equipped with modern intensive care unit facilities is recommended in West Bengal to prevent the burden of eclampsia‐related maternal death.

AUTHOR CONTRIBUTION

Md Illias Kanchan Sk: conceptualization, data curation, methodology, formal analysis, investigation, software and writing − original draft preparation, review and editing.

CONFLICT OF INTEREST

The author declares no conflict of interest.

ETHICS STATEMENT

The Institutional Ethics Committee for Human Research (IECHR) of Medical College and Hospital, Kolkata and Malda Medical College and Hospital approved the study. The whole analysis was performed anonymously. Confidentiality was maintained during data collection, storage, and analysis.

INFORMED CONSENT

Written consent to undertake the study was provided by the Ministry of Health and Family Welfare (MoHFW), Government of West Bengal. Prior written consent was also obtained from all family members to conduct the community‐based in‐depth interviews.

ACKNOWLEDGMENTS

I would like to thank the Principals and Registrars of Kolkata and Malda Medical Colleges and Hospitals for providing maternal death‐related data. I am grateful to Prof. Balram Paswan and Prof. T. K. Naskar for their continuous insight and guidance during my research. I am also thankful to Mr. Sandeep Chatterjee, Mr. Samiun Mondal, and Dr. Ismile Sheikh, the assistant superintendent of the respective medical college and hospitals, for their help in completinge this study. The author received no financial support for the research, authorship, and/or publication of this article.

Sk MIK. Socioeconomic and epidemiological milieu of maternal death due to eclampsia in West Bengal, India: a mixed methods study. Health Care Sci. 2023;2:45–59. 10.1002/hcs2.28

DATA AVAILABILITY STATEMENT

The data set analyzed for this study is available with corresponding author which can be accessed on reasonable request. Anonymized data without participant's identification will be made available. The data are not publicly available due to privacy or ethical restrictions.

REFERENCES

  • 1. Von Dadelszen P, Bhutta ZA, Sharma S, Bone J, Singer J, Wong H, et al. The community‐level interventions for pre‐eclampsia (CLIP) cluster randomised trials in Mozambique, Pakistan, and India: an individual participant‐level meta‐analysis. Lancet. 2020;396(10250):553–63. 10.1016/S0140-6736(20)31128-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk factors of pre‐eclampsia/eclampsia and its adverse outcomes in low‐and middle‐income countries: a WHO secondary analysis. PLoS One. 2014;9(3):e91198. 10.1371/journal.pone.0091198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Hug L, Alexander M, You D, Alkema L. National, regional, and global levels and trends in neonatal mortality between 1990 and 2017, with scenario‐based projections to 2030: a systematic analysis. Lancet Global Health. 2019;7(6):e710–20. 10.1016/S2214-109X(19)30163-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Lozano R, Wang H, Foreman KJ, Rajaratnam JK, Naghavi M, Marcus JR, et al. Progress towards millennium development goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet. 2011;378(9797):1139–65. 10.1016/S0140-6736(11)61337-8 [DOI] [PubMed] [Google Scholar]
  • 5. Malik A, Jee B, Gupta SK. Preeclampsia: disease biology and burden, its management strategies with reference to India. Pregnancy Hyper. 2019;15:23–31. 10.1016/j.preghy.2018.10.011 [DOI] [PubMed] [Google Scholar]
  • 6. Nobis PN, Hajong A. Eclampsia in India through the decades. J Obstetrics Gynecol India. 2016;66(1):172–6. 10.1007/s13224-015-0807-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Ahmed KY, Rwabilimbo AG, Abrha S, Page A, Arora A, Tadese F, et al. Factors associated with underweight, overweight, and obesity in reproductive age Tanzanian women. PLoS One. 2020;15(8):e0237720. 10.1371/journal.pone.0237720 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Lisowska M, Pietrucha T, Sakowicz A. Preeclampsia and related cardiovascular risk: common genetic background. Curr Hypertens Rep. 2018;20(8):71. 10.1007/s11906-018-0869-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Meyur R, Sadhu A, Mondal H, Khanra SK. A light microscopic study of placentae in eclamptic mothers at term. J Res Med Sci. 2017;5(9):4082–6. 10.18203/2320-6012.ijrms20173987 [DOI] [Google Scholar]
  • 10. Magee LA, Sharma S, Nathan HL, Adetoro OO, Bellad MB, Goudar S, et al. The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: a prospective population‐level analysis. PLoS Med. 2019;16(4):e1002783. 10.1371/journal.pmed.1002783 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Agrawal S, Walia GK, Staines‐Urias E, Casas JP, Millett C. Prevalence of and risk factors for eclampsia in pregnant women in India. Family Med Community Health. 2017;5(4):225–44. 10.15212/FMCH.2016.0121 [DOI] [Google Scholar]
  • 12. Das R, Biswas S. Eclapmsia: the major cause of maternal mortality in eastern India. Ethiop J Health Sci. 2015;25(2):111–6. 10.4314/ejhs.v25i2.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Bhattacharyya SK, Majhi AK, Seal SL, Mukhopadhyay S, Kamilya G, Mukherji J. Maternal mortality in India: a 20‐year study from a large referral medical college hospital, West Bengal. J Obstetrics Gynaecol Res. 2008;34(4):499–503. 10.1111/j.1447-0756.2008.00721.x [DOI] [PubMed] [Google Scholar]
  • 14. Sk MIK, Paswan B, Anand A, Chowdhury P, Naskar TK. Deaths during pregnancy, childbirth and puerperium: exploring causes, context and evidence from Eastern India. J Obstetrics Gynaecol Res. 2020;46:2366–74. 10.1111/jog.14466 [DOI] [PubMed] [Google Scholar]
  • 15. Jana N, Barik S, Arora N. Re: clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey: Magnesium sulphate regimens for eclampsia: should we adopt same'goldstandard'for all women. BJOG: Int J Obstetrics Gynaecol. 2018;125(7):909. 10.1111/1471-0528.15149 [DOI] [PubMed] [Google Scholar]
  • 16. Ronsmans C, Campbell O. Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy. BMC Public Health. 2011;11(S3):S8. 10.1186/1471-2458-11-S3-S8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. NIPCCD . An analysis of levels and trends in maternal health and maternal mortality ratio in India. 2015. National Institute of Public Cooperation and Child Development.
  • 18. WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division.  Trends in maternal mortality: 1990 to 2015: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. 2016. World Health Organization; 2015. http://apps.who.int/iris/bitstream/handle/10665/194254/9789241565141_eng.pdf;jsessionid=6E186501EC864EC6A3019A72554201BA
  • 19. Goldenberg RL, McClure EM, MacGuire ER, Kamath BD, Jobe AH. Lessons for low‐income regions following the reduction in hypertension‐related maternal mortality in high‐income countries. Int J Gynaecol Obstetrics. 2011;113(2):91–5. 10.1016/j.ijgo.2011.01.002 [DOI] [PubMed] [Google Scholar]
  • 20. Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of gynecology and obstetrics (FIGO) initiative on pre‐eclampsia: a pragmatic guide for first‐trimester screening and prevention. Intl J Gynaecol Obstetrics. 2019;145(suppl 1):1–33. 10.1002/ijgo.12802 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Chaemsaithong P, Poon LC, Sahota DS. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226:S1071–97. 10.1016/j.ajog.2020.07.020 [DOI] [PubMed] [Google Scholar]
  • 22. Aukes AM, Arion K, Bone JN, Li J, Vidler M, Bellad MB, et al. Causes and circumstances of maternal death: a secondary analysis of the community‐level interventions for pre‐eclampsia (CLIP) trials cohort. Lancet Global Health. 2021;9(9):e1242–51. 10.1016/S2214-109X(21)00263-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Keskinkılıç B, Engin Üstün Y, Sanisoğlu S, Şahin Uygur D, Keskin HL, Karaahmetoğlu S, et al. Maternal mortality due to hypertensive disorders in pregnancy, childbirth, and the puerperium between 2012 and 2015 in Turkey: a nation‐based study. J Turkish‐German Gynecol Assoc. 2017;18(1):20–5. 10.4274/jtgga.2016.0244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Abejirinde IOO, Douwes R, Bardají A, Abugnaba‐Abanga R, Zweekhorst M, van Roosmalen J, et al. Pregnant women's experiences with an integrated diagnostic and decision support device for antenatal care in Ghana. BMC Pregnancy Childbirth. 2018;18(1):209. 10.1186/s12884-018-1853-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Yaliwal RG, Jaju PB, Vanishree M. Eclampsia and perinatal outcome: a retrospective study in a teaching hospital. J of Clin and Diagn Res. 2011;5(5):1056–9. 10.7860/JCDR/2011/.1527 [DOI] [Google Scholar]
  • 26. Worke MD, Enyew HD, Dagnew MM. Magnitude of maternal near misses and the role of delays in Ethiopia: a hospital based cross‐sectional study. BMC Res Notes. 2019;12(1):585. 10.1186/s13104-019-4628-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Braunthal S, Brateanu A. Hypertension in pregnancy: pathophysiology and treatment. SAGE Open Med. 2019;7:1–15. 10.1177/2050312119843700 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Mohta M, Duggal S, Chilkoti GT. Randomised double‐blind comparison of bolus phenylephrine or ephedrine for treatment of hypotension in women with pre‐eclampsia undergoing caesarean section. Anaesthesia. 2018;73(7):839–46. 10.1111/anae.14268 [DOI] [PubMed] [Google Scholar]
  • 29. Amorim MM, Souza ASR, Katz L. Planned caesarean section versus planned vaginal birth for severe pre‐eclampsia. Cochrane Database Syst Rev. 2017;10:1–18. 10.1002/14651858.CD009430.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Mazda Y, Tanaka M, Terui K, Nagashima S, Inoue R. Postoperative renal function in parturients with severe preeclampsia who underwent cesarean delivery: a retrospective observational study. J Anesth. 2018;32(3):447–51. 10.1007/s00540-018-2492-x [DOI] [PubMed] [Google Scholar]
  • 31. Sarkar S. Prevalence and determinants of the use of caesarean section (CS) in the dichotomy of ‘public’ and ‘private’ health facilities in West Bengal. India. Clin Epidemiol Global Health. 2020;8:1377–83. 10.1016/j.cegh.2020.05.017 [DOI] [Google Scholar]
  • 32. IIPS . National Family Health Survey (NFHS‐4) 2015‐16. International Institute for Population Sciences (IIPS). 2017.
  • 33. Skjærven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med. 2002;346(1):33–8. 10.1056/NEJMoa011379 [DOI] [PubMed] [Google Scholar]
  • 34. Graham NM, Gimovsky AC, Roman A, Berghella V. Blood loss at cesarean delivery in women on magnesium sulfate for preeclampsia. J Maternal‐fetal Neonatal Med. 2016;29(11):1817–21. 10.3109/14767058.2015.1064107 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data set analyzed for this study is available with corresponding author which can be accessed on reasonable request. Anonymized data without participant's identification will be made available. The data are not publicly available due to privacy or ethical restrictions.


Articles from Health Care Science are provided here courtesy of Wiley on behalf of Tsinghua University Press

RESOURCES